Phase IV study of afatinib as second-line therapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring common epidermal growth factor receptor (EGFR) mutations (Del19 and/or L858R)

Thongprasert, Sumitra; ...; Jovanovic, D; ...; Petrovic, M; ...; Radosavljevic, Davorin Z; Perin, Branislav M; ...; (broj, koautora 19)

Results

eNauka > Results > Phase IV study of afatinib as second-line therapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring common epidermal growth factor receptor (EGFR) mutations (Del19 and/or L858R)

Title:	Phase IV study of afatinib as second-line therapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring common epidermal growth factor receptor (EGFR) mutations (Del19 and/or L858R)
Authors:	Thongprasert, Sumitra; ...; Jovanovic, D; ...; Petrovic, M; ...; Radosavljevic, Davorin Z; Perin, Branislav M; ...; (broj, koautora 19)
Issue Date:	2015
Publication:	ANNALS OF ONCOLOGY
ISSN:	0923-7534 Annals of Oncology Search Idenfier
Type:	Conference Paper
Collation:	vol. 26 str. 146-146
WoS-ID:	000367158700476
URI:	https://enauka.gov.rs/handle/123456789/808695
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM